Valuation: 3SBio Inc.

Capitalization 64.27B 70.76B 9.09B 7.81B 7.32B 6.82B 12.6B 818B 13.71B 85.62B 33.06B 386B 34.12B 33.39B 1,413B P/E ratio 2025 *
6.89x
P/E ratio 2026 * 19.6x
Enterprise value 56.82B 62.57B 8.04B 6.91B 6.47B 6.03B 11.14B 723B 12.12B 75.7B 29.23B 342B 30.17B 29.52B 1,249B EV / Sales 2025 *
3.08x
EV / Sales 2026 * 4.68x
Free-Float
72.15%
Yield 2025 *
2.65%
Yield 2026 * 1.72%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.47%
1 week-5.37%
Current month-5.37%
1 month-3.90%
3 months-17.05%
6 months+46.44%
Current year+386.51%
More quotes
1 week 29.08
Extreme 29.08
31.74
1 month 26.74
Extreme 26.74
35.42
Current year 5.6
Extreme 5.6
36.8
1 year 5.6
Extreme 5.6
36.8
3 years 4.91
Extreme 4.91
36.8
5 years 4.72
Extreme 4.72
36.8
10 years 4.72
Extreme 4.72
36.8
More quotes
Manager TitleAgeSince
Chief Executive Officer 62 31/12/2005
Director of Finance/CFO - 02/07/2023
Corporate Officer/Principal 55 26/11/2014
Director TitleAgeSince
Chairman 62 02/04/2012
Director/Board Member 55 10/06/2012
Director/Board Member 56 31/05/2015
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.47%-5.37%+377.87%+272.08% 9.09B
-0.61%-7.92%-7.67%-3.89% 73.7B
-0.81%-1.18%-34.44%-38.79% 58.94B
+3.17%+2.91%+33.57%+247.91% 54.7B
-2.32%+64.10%+64.10%+64.10% 51.57B
-0.37%-0.43%+14.91%-37.80% 26.6B
-1.66%-2.23%+143.39%+224.51% 20.25B
+2.05%-1.86%+35.04%+24.21% 20.13B
-12.04%-14.35%+49.18%+1,058.63% 16.58B
-1.50%+2.26%+155.78%+687.59% 14.19B
Average -1.46%-3.01%+83.17%+249.85% 34.58B
Weighted average by Cap. -0.77%-2.58%+37.64%+139.12%
See all sector performances

Financials

2025 *2026 *
Net sales 18.44B 20.31B 2.61B 2.24B 2.1B 1.96B 3.62B 235B 3.93B 24.57B 9.49B 111B 9.79B 9.58B 405B 11.66B 12.84B 1.65B 1.42B 1.33B 1.24B 2.29B 148B 2.49B 15.53B 6B 70.08B 6.19B 6.06B 256B
Net income 9.47B 10.43B 1.34B 1.15B 1.08B 1.01B 1.86B 121B 2.02B 12.62B 4.87B 56.95B 5.03B 4.92B 208B 3.34B 3.68B 473M 406M 381M 355M 655M 42.54B 713M 4.45B 1.72B 20.09B 1.77B 1.74B 73.46B
Net Debt -7.44B -8.19B -1.05B -905M -848M -790M -1.46B -94.72B -1.59B -9.91B -3.83B -44.74B -3.95B -3.87B -164B -9.69B -10.67B -1.37B -1.18B -1.1B -1.03B -1.9B -123B -2.07B -12.91B -4.99B -58.28B -5.15B -5.04B -213B
More financial data * Estimated data
Logo 3SBio Inc.
3SBio Inc is an investment holding company mainly engaged in the development, production, marketing and sale of pharmaceutical products. The Company’s core products include several biopharmaceutical drugs, TPIAO, recombinant human erythropoietin(rhEPO) products, with brand of EPIAO and SEPO, Yisaipu, Cipterbin and a small molecule drug, Mandi and tumor necrosis factor (TNF). Through its subsidiaries, the Company is engaged in project management and consultation. The Company still engages in developing innovative biological products, including mAbs, bi-specific antibodies and fusion proteins, and a number of small molecule drugs, both innovative and generic, in the areas of nephrology, oncology, auto-immune and inflammatory diseases, ophthalmology and dermatological diseases. The Company distributes its products within the domestic market and to overseas markets.
Employees
6,268
More about the company
Date Price Change Volume
05/12/25 29.58 $ -0.47% 9,193,101
04/12/25 29.72 $ +1.43% 19,623,650
03/12/25 29.30 $ -3.04% 25,661,780
02/12/25 30.22 $ -4.61% 46,486,110
01/12/25 31.68 $ +1.34% 16,401,240

Delayed Quote Hong Kong S.E., December 05, 2025 at 08:09 am

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
26.86CNY
Average target price
34.74CNY
Spread / Average Target
+29.32%
Consensus

Quarterly revenue - Rate of surprise